Intercept Pharmaceuticals | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amarin USD 119.52M 1.51M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Arrowhead Research USD 185.71M 133.92M 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Biogen USD 2.6B 223.3M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Moderna USD 1.62B 304M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12
PTC Therapeutics USD 2.03B 1.25B 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Intercept Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.